Utama › Sklerosis Pelbagai › New York › New York City
Kajian klinikal Sklerosis Pelbagai di New York City, NY
17 kajian untuk Sklerosis Pelbagai sedang mencari peserta di lokasi dalam dan sekitar New York City (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study of the MIND Diet for Persons With Multiple Sclerosis
Mengambil peserta
- Mount Sinai Hospital, New York
Vancomycin Study in Multiple Sclerosis (MS)
Mengambil pesertaFasa 1
- Corinne Goldsmith Dickinson Center for Multiple Sclerosis at Mount Sinai, New York
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Mengambil pesertaFasa 1
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- NYP/Weill Cornell Medical Center, New York
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Mengambil pesertaKajian pemerhatian
- TG Therapeutics Investigational Trial Site, New York
Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis
Mengambil pesertaFasa 1/2
- Mt. Sinai, New York
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Mengambil pesertaFasa 2
- NYU Langone Health, New York
A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
Mengambil pesertaFasa 1
- TG Therapeutics Investigational Trial Site, New York
An Open-label Study of AZD0120 in Adults With Multiple Sclerosis
Mengambil pesertaFasa 1
- Research Site, New York
- Research Site, New York
A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases
Mengambil pesertaFasa 1
- Columbia University Irving Medical Center, New York
Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis
Mengambil pesertaFasa 2
- Mount Sinai School of Medicine, New York
Home-Based Transcranial Direct Current Stimulation (tDCS) for Depression in Multiple Sclerosis (MS)
Mengambil pesertaFasa 2
- NYU Langone Health, New York
Longitudinal Cortical Demyelination in Multiple Sclerosis and Related Disorders
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Mount Sinai Hospital, New York
Genes and Environment in Multiple Sclerosis
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Columbia University Irving Center, New York
A Palliative Care Model Impact on Knowledge and Attitudes
Mengambil peserta
- Judith Jaffe Multiple Sclerosis Center, New York
- Hunter College, New York
NYSCF Scientific Discovery Biobank
Mengambil pesertaKajian pemerhatian
- New York Stem Cell Foundation Research Institute, New York
Eccentric Exercise and Fatigue in Multiple Sclerosis
Mengambil pesertaKajian pemerhatian
- Hunter College, Physical Therapy Department, City University of New York, New York
Effect of Cooling on Balance Performance in Multiple Sclerosis
Mengambil pesertaKajian pemerhatian
- Hunter College, Physical Therapy Department, City University of New York, New York
Kajian Sklerosis Pelbagai di bandar lain
- Chicago, IL15 kajian
- Boston, MA14 kajian
- Washington, DC13 kajian
- Cleveland, OH9 kajian
- St. Louis, MO8 kajian
- Kansas City, KS8 kajian
- Birmingham, AL8 kajian
- San Francisco, CA8 kajian
- Columbus, OH7 kajian
- Aurora, CO7 kajian
- Baltimore, MD7 kajian
- Farmington Hills, MI6 kajian
Kajian lain di New York City
- Kanser Payudara134 kajian
- Kanser Paru-paru Bukan Sel Kecil120 kajian
- Kanser (semua jenis)110 kajian
- Kanser Prostat103 kajian
- Kanser Metastatik93 kajian
- Kanser Kolorektal77 kajian
- Kanser Ovari69 kajian
- Kanser Paru-paru60 kajian
- Kanser Pankreas60 kajian
- Mieloma Pelbagai60 kajian
- Kanser Endometrium52 kajian
- Kegagalan Jantung51 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.